Extra-adrenal and adrenal pheochromocytomas associated with a germline SDHC mutation

[1]  M. Mannelli,et al.  Genetic screening for pheochromocytoma: should SDHC gene analysis be included? , 2007, Journal of Medical Genetics.

[2]  Charis Eng,et al.  Cancer phenomics: RET and PTEN as illustrative models , 2007, Nature Reviews Cancer.

[3]  H. Neumann,et al.  Pheochromocytoma: presentation, diagnosis and treatment. , 2006, Journal of hypertension.

[4]  C. Eng,et al.  Comprehensive mutation scanning of NF1 in apparently sporadic cases of pheochromocytoma. , 2006, The Journal of clinical endocrinology and metabolism.

[5]  A. Gimenez-Roqueplo,et al.  The genetic basis of pheochromocytoma: who to screen and how? , 2006, Nature Clinical Practice Endocrinology &Metabolism.

[6]  K. Schmid,et al.  Laparoscopic and Retroperitoneoscopic Treatment of Pheochromocytomas and Retroperitoneal Paragangliomas: Results of 161 Tumors in 126 Patients , 2006, World Journal of Surgery.

[7]  Peter Devilee,et al.  Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma , 2006, BMC Medical Genetics.

[8]  C. Eng,et al.  Predictors and prevalence of paraganglioma syndrome associated with mutations of the SDHC gene. , 2005, JAMA.

[9]  M. Imamura,et al.  Changing Treatment Strategy for Gastrinoma in Patients with Zollinger-Ellison Syndrome , 2005, World Journal of Surgery.

[10]  C. Eng,et al.  Distinct clinical features of paraganglioma syndromes associated with SDHB and SDHD gene mutations. , 2004, JAMA.

[11]  Charis Eng,et al.  A role for mitochondrial enzymes in inherited neoplasia and beyond , 2003, Nature Reviews Cancer.

[12]  G. Chrousos,et al.  The molecular pathogenesis of hereditary and sporadic adrenocortical and adrenomedullary tumors. , 2002, The Journal of clinical endocrinology and metabolism.

[13]  J. Strauchen.  Germ-line mutations in nonsyndromic pheochromocytoma. , 2002, The New England journal of medicine.

[14]  E S Husebye,et al.  Gene mutations in the succinate dehydrogenase subunit SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. , 2001, American journal of human genetics.

[15]  K. Bohuslavizki.  Somatostatin receptor imaging: current status and future perspectives. , 2001, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[16]  C. Eng,et al.  Somatic and occult germ-line mutations in SDHD, a mitochondrial complex II gene, in nonfamilial pheochromocytoma. , 2000, Cancer research.

[17]  Ulrich Müller,et al.  Mutations in SDHC cause autosomal dominant paraganglioma, type 3 , 2000, Nature Genetics.

[18]  B. Devlin,et al.  Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. , 2000, Science.

[19]  F. Messerli,et al.  Clinical and Experimental Pheochromocytoma , 1997 .